General

Cartherics Therapies More Essential Than Ever

New research delivers devastating findings about ovarian cancer screening

Four Australian women are diagnosed with ovarian cancer a day and three will eventually die from the disease. It’s usually diagnosed late, because few women show symptoms until they have advanced cancer.

As a junior doctor in London in the mid-1980s, Ian Jacobs saw women undergo chemo and […]

2021-05-20T14:20:54+10:00May 20th, 2021|

Next Wave AntiCancer Therapies

The first in a provocative series on the complexities of advanced therapeutic approaches to cancer

By Jeff Brockman and Joel Sandler of Cello Health BioConsulting

“In 1890, the Russian playwright and physician Anton Chekov (pictured above) wrote a letter in which he alluded to a centuries-old observation that infections seemed to slow the growth of […]

2021-05-06T12:03:23+10:00May 6th, 2021|

Cartherics Announces Grant of European Patent

First patented product to enter clinic within two years 

Melbourne, Australia, 04 March 2021.

Cartherics Pty Ltd announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”.  The patent covers aspects of Cartherics’ chimeric antigen receptor (CAR) technology, particularly in relation to its CAR directed against the tumour-associated antigen, TAG-72.

This patent is […]

2021-03-09T10:51:27+11:00March 9th, 2021|

Cartherics CEO Alan Trounson remembers Dolly and welcomes Elizabeth Ann

Dolly the cloned sheep is a legend. Not so her technical descendant Elizabeth Ann the endangered black-footed ferret.

By Leigh Dayton

4 March 2021

In 1966 Alan Trounson was enjoying a hike in the hills above Edinburgh, Scotland with his colleague Ian Wilmut when Wilmut revealed a secret. His team at the Roslin Institute had cloned a […]

2021-03-04T11:35:02+11:00March 4th, 2021|

Cartherics welcomes new PhD Student

Monash Grad Rachelle Duffin joins the team

1 March 2021

By Leigh Dayton

Fresh from a Research Assistant job at the Peter MacCallum Cancer Centre and a Bachelor of Science (Honours) from Monash University, Rachelle Duffin took up her new role at Cartherics at the beginning of February.

She’s “delighted and honoured” to be supervised by Cartherics […]

2021-03-01T00:30:55+11:00March 1st, 2021|

Cartherics Makes February 2021 A Special Month

It all happened at Cape Schanck ……

By Leigh Dayton

24 February 2021

2020 was a rough year everywhere for everyone, including Cartherics’ hard-working team. By way of a thank you CEO Alan Trounson, Chairman Bob Moses and Chief Operating Officer Ian Nisbet hosted a company come-one come-all event this month at the Royal Automobile Club […]

2021-02-24T06:25:41+11:00February 24th, 2021|

CAR-T Funding is Reaching Staggering New Heights

A survey reveals nearly US$100 market capitalisation

23 February 2021

A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.

At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]

2021-04-28T12:42:46+10:00February 23rd, 2021|

Cartherics CEO Alan Trounson on “3-person IVF”

Legislation to be introduced to Australian Parliament

By Leigh Dayton

4 February 2021

Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.

Thanks to this […]

2021-02-04T03:41:18+11:00February 4th, 2021|

Cartherics Celebrates Academic Achievements

Doctoral students achieve key milestones

 By Leigh Dayton

21 December 2020

As a rough year for all comes to an end, Cartherics is delighted to raise a toast to Anisha Balachandran and Van Thi To.  Anisha dressed-up for a pared-down graduation ceremony, and Van passed her Confirmation of Candidature Review with flying colours.

Cartherics CEO Alan Trounson is the […]

2020-12-21T06:35:40+11:00December 21st, 2020|

The Power Of The Pivot – Lessons from the biotech frontline

Back People Not Projects

By Ian Nisbet*

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)

In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]

2020-11-19T01:14:44+11:00November 19th, 2020|
Go to Top